Use of gabapentin for the management of natural or surgical menopausal hot flashes

Annals of Pharmacotherapy

Volumn 45, Issue 3, 2011, Pages 388-394

  Hayes, Laura P ^a   Carroll, Dana G ^a   Kelley, Kristi W ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Gabapentin; Hot flashes; Menopause

Indexed keywords

CONJUGATED ESTROGEN; GABAPENTIN; PLACEBO;

DISORIENTATION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; ESTROGEN THERAPY; GASTROINTESTINAL SYMPTOM; HEART PALPITATION; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MENOPAUSE; META ANALYSIS; MORBIDITY; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE SIZE; SCORING SYSTEM; SOMNOLENCE; SPOTTING; SYSTEMATIC REVIEW; UNSTEADINESS; VAGINA BLEEDING;

AMINES; CALCIUM CHANNEL BLOCKERS; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HOT FLASHES; HUMANS; MENOPAUSE; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UTERINE DISEASES;

EID: 79952632468     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P366     Document Type: Review

References (37)

1. Treatment of menopause-associated vasomotor symptoms: the North American Menopause Society. Menopause 2004;11:11-33. DOI 10.1097/01.GME.0000108177.85442. 71
2. Freedman RR. Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med 2005;23:117-25. DOI 10.1055/s-2005-86947910.1097/gme. 0b013e31817b076a (Pubitemid 40604897)
3. Shanafelt TD, Barton DL, Adiei AA, Loprinizi CL. Pathophysiology and treatment of hot flashes. Mayo Clinic Proc 2002;77:1207-18. DOI 10.4065/77.11.1207 (Pubitemid 35266369)
4. Rossouw JE, Anderson GL, Prentice RL, et al.; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy menopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33. DOI 10.1001/jama.288.3.321
5. Guttuso TJ. Gabapentin's effects on hot flashes and hypothermia. Neurology 2000;54:2161-2163.
6. Albertazzi P, Bottazzi M, Purdie DW. Gabapentin for the management of hot flushes: a case series. Menopause 2003;10:214-7. DOI 10.1097/00042192- 200310030-00007 (Pubitemid 36706305)
7. Guttuso TJ. Hot flashes refractory to HRT and SSRI therapy but responsive to gabapentin. J Pain Symptom Manage 2004;27:274-6. DOI 10.1016/jjpainsymman. 2003.07.007
8. Pandya KJ, Thummala AR, Griggs JJ, et al. Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer. Breast Cancer Res Treat 2004;83:87-9. DOI 10.1023/B.BREA.0000010676.54597.22 (Pubitemid 38141896)
9. Pandya KJ, Morrow GR, Roscoe JA, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomized double blind placebo-controlled trial. Lancet 2005;366:818-24. DOI 10.1016/S0140-6736(05)67215-7 (Pubitemid 41557381)
10. Biglia N, Sgandurra P, Peano E, et al. Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs vitamin E. Cilmacteric 2009;12:310-8. DOI 10.1080/136971300902736921
11. Guttuso T Jr, Kurlan R, McDermott MP, Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003;101:337-45. DOI 10.1016/S0029-7844(02)02712-6 (Pubitemid 36170136)
12. Reddy SY, Warner H, Guttuso T, et al. Gabapentin, estrogen and placebo for treating hot flushes. A randomized controlled trial. Obstet Gynecol 2006;108:41-48.
13. Butt DA, Lock M, Lewis JE, Ross S, Moineddin R. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled clinical trial. Menopause 2008;15:310-8. DOI 10.1097/gme.0b013e3180dca175 (Pubitemid 351354993)
14. Aguirre W, Chedraui P, Mendoza J, Ruilova I. Gabapentin vs low dose transdermal estradiol for treating postmenopausal women with moderate to very severe hot flushes. Gynecol Endocrinol 2010;26:333-337. DOI 10.3109/ 09513590903511539
15. MacLennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progesten therapy versus placebo for hot flushes. Cochrane Syst Rev 2004(4):CD002978. DOI 10.1002/14651858.CD002978.pub2
16. Stearns V, Issacs C, Rowland J, et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol 2000;11:17-22. DOI 10.1023/A:1008382706068 (Pubitemid 30084574)
17. Stearns V, Slack E, Greep N, et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 2005;23:6919-30. DOI 10.1200/JCO.2005.10.08
18. Soares CN, Joffe H, Viguera AC, et al. Paroxetine versus placebo for women in midlife after hormone discontinuation. Am J Med 2008;121:159-62. DOI 10.1016/j.amjmed.2007.10.007
19. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in the management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet 2000;356:2059-63. DOI 10.1016/S0140-6736(00)03403-6 (Pubitemid 32009821)
20. Barton D, La VB, Loprinzi C, Novonty P, Wilwerding MB, Sloan J. Venlafaxine for the control of hot flashes: results of a longitudinal continuation study. Oncol Nurs Forum 2002;29:33-40. DOI 10.1188/02.ONF.33-40
21. Carpenter JS, Storniolo AM, Johns S, et al. Randomized, double-blind, placebo-controlled crossover trial of venlafaxine for hot flashes after breast cancer. Oncologist 2007;12:124-34. DOI 10.1634/theoncologist.12-1-124
22. Loibl S, Schwedler K, Von Minckwitz G, Strohmeier R, Mehta KM, Kaufmann M. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients - a double blind, randomized study. Ann Oncol 2007;18:689-93. DOI 10.1093/annonc/mdl478 (Pubitemid 46523272)
23. Loprinzi CL, Levitt R, Barton D, et al. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Treatment Group trial N99C7. J Clin Oncol 2006;24:1409-14. DOI 10.1200/JCO.2005.04.7324 (Pubitemid 46622006)
24. Evans ML, Pritts E, Vittinghoff E, McClish K, Morgan KS, Jaffe RB. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized controlled trial. Obstet Gynecol 2005;105:161-6. DOI 10.1097/01.AOG.0000147840.06947.46 (Pubitemid 40189927)
25. Ladd CO, Newport J, Raga KA, Loughhead A, Stowe ZN. Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression. Depress Anxiety 2005;22:94-7. DOI 10.1002/da.20085 (Pubitemid 41598045)
26. Newton KM, Reed SD, LaCroix AZ, et al. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy or placebo. Ann Intern Med 2006;145:869-879. (Pubitemid 351639962)
27. Pockaj BA, Gallagher JG, Loprinzi CL, et al. Phase III double-blind, placebo-controlled, crossover trial of black cohosh in the management of hot flashes: NCCTG trial N01CC. J Clin Oncol 2006;24:2836-41. DOI 10.1200/JCO.2005.05.4296 (Pubitemid 46630583)
28. Pockaj BA, Loprinzi CL, Sloan JA, et al. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest 2004;22:515-21. DOI 10.1081/CNV-200026394 (Pubitemid 39506871)
29. Vermes G, Banhidy F, Acs N. The effects of Remifemin on subjective symptoms of menopause. Adv Ther 2005;22:148-54. DOI10.1007/BF02849885
30. Hernández Muñoz G, Pluchino S. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Matruritas 2003;44(suppl 1):S59-65. DOI 10.1016/SO378-5122(02)00349-3
31. Wuttke W, Seidlova-Wuttke D, Gorkow C. The cimicifuga preparation BNO 1005 vs conjugated estrogens in double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003;44 (suppl 1):S67-77. DOI 10.1016/SO378-5122(02)00350-X
32. Nappi RE, Malavasi B, Brundu B, Facchinetti F. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus lowdose transdermal estradiol. Gynecol Endocrinol 2005;20:30-5. DOI 10.1080/ 09513590400020922 (Pubitemid 40445238)
33. Oktem M, Eroglu D, Karahan HB, et al. Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial. Adv Ther 2007;24:448-61. DOI 10.1007/BF02849914 (Pubitemid 46988389)
34. Bai W, Zepelin HH, Wang S, et al. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone. Maturitas 2007;58:31-41. DOI 10.1016/j.maturitas.2007.04. 009 (Pubitemid 47268705)
35. Frei-Kleiner S, Schaffner W, Rahlfs VW, et al. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double blind placebo-controlled clinical trial. Maturitas 2005;51:397-404. DOI 10.1016/j.maturitas.2004.10.003 (Pubitemid 41019367)
36. Lethaby AE, Brown J, Marjoribanks J, et al. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Syst Rev 2007;4:1-64. DOI 10.1002/14651858. CD001395.pub3
37. Package insert. Neurontin (gabapentin). New York, NY: Pfizer, Inc., July 2010. http://www.pfizer.com/files/products/uspi-neurontin.pdf (accessed 2010 Nov 19).